Keine Story von AstraZeneca LP mehr verpassen.

AstraZeneca LP

  • 03.09.2004 – 08:01

    New European Study Examines the Role of Insulin Resistance in Predicting Cardiovascular Disease

    London and Brussels (ots/PRNewswire) - - RISC Study, Largest of its Kind, Reaches Recruitment Milestone The European Group for the study of Insulin Resistance (EGIR) announced today that the clinical trial recruitment milestone of 1,200 subjects has been reached in the Relationship between Insulin Sensitivity and Cardiovascular disease risk (RISC) study - ...